US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Roivant Sciences Ltd.

26.52

-0.8300-3.03%

Post-market: 26.00-0.5200-1.96%19:51 EDT

Volume:3.01M

Turnover:80.67M

Market Cap:18.98B

PE:-22.60

High:27.51

Open:27.26

Low:26.47

Close:27.35

52wk High:30.33

52wk Low:8.73

Shares:715.70M

Float Shares:467.00M

Volume Ratio:0.38

T/O Rate:0.64%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.1734

EPS(LYR):-0.2371

ROE:-19.14%

ROA:-14.47%

PB:4.45

PE(LYR):-111.86

Loading ...

Overview Company News Filings

Wall Street Set to Open Modestly Higher Friday as Tech Stocks Stabilize Following Week-Long Rout

MT Newswires Live

BRIEF-Priovant Announces Positive Phase 2 Results For Brepocitinib In Cutaneous Sarcoidosis (Cs)

Priovant's Brepocitinib Shows Skin Disease Improvement in Phase 2 Study; Pulmovant Completes Lung Disease Trial Enrollment

MT Newswires Live

Shares of Roivant up 15.8% Premarket After Experimental Drug Shows Benefit in Rare Skin Disease, Q3 Results

THOMSON REUTERS

Roivant Sciences posts nine-month revenue of USD 5.74 million, down 73 percent

S&P 500 Futures Climb In Premarket Trading; Doximity, Stellantis Lag

BUZZ-Roivant shares rise as experimental drug shows benefit in rare skin disease

Roivant swings to Q3 loss as revenue drops

Earnings Flash (ROIV) Roivant Sciences Posts Fiscal Q3 Net Loss $0.38 a Share, vs. FactSet Est of $0.30 Loss

MT Newswires Live

Stock Track | Roivant Sciences Soars 9.93% in Pre-market on Positive Phase 2 Results for Brepocitinib

Immunovant Q3 net loss smaller than expected

Roivant Sciences Q3 Adj. EPS $(0.24) Beats $(0.32) Estimate, Sales $1.999M

BRIEF-Roivant Sciences Q3 Revenue USD 1.999 Million

Priovant Therapeutics kündigt positive Phase-2-Studie mit Brepocitinib bei kutaner Sarkoidose an

Roivant Sciences Q3 Operating Expenses USD 341.152 Million

THOMSON REUTERS

Roivant Sciences Ltd - Brepocitinib 45 Mg Shows Significant Improvement in Cutaneous Sarcoidosis

THOMSON REUTERS

Roivant Sciences Ltd: Jury Trial in the U.S. Moderna Case Scheduled for March 2026

THOMSON REUTERS

Roivant Announces Positive Phase 2 Results for Brepocitinib in Cutaneous Sarcoidosis (Cs) and Reports Financial Results for the Third Quarter Ended December 31, 2025

THOMSON REUTERS

Roivant Sciences Ltd - Topline Results Expected in Second Half of 2026

THOMSON REUTERS

Pulmovant Announces Completion of Enrollment in the Phase 2 Phocus Study of Mosliciguat in Patients With Pulmonary Hypertension Associated With Interstitial Lung Disease (Ph-Ild)

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ROIV/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ROIV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ROIV\",,,,,undefined,":{"symbol":"ROIV","market":"US","secType":"STK","nameCN":"Roivant Sciences Ltd.","latestPrice":26.52,"timestamp":1774641600000,"preClose":27.35,"halted":0,"volume":3011878,"hourTrading":{"tag":"盘后","latestPrice":26,"preClose":26.52,"latestTime":"19:51 EDT","volume":60579,"amount":1603294.66,"timestamp":1774655502579,"change":-0.52,"changeRate":-0.019608,"amplitude":0.038462},"delay":0,"changeRate":-0.03034734917733096,"floatShares":467000000,"shares":715701137,"eps":-1.173433,"marketStatus":"Closed","change":-0.83,"latestTime":"03-27 16:00:00 EDT","open":27.26,"high":27.51,"low":26.47,"amount":80670004.81749,"amplitude":0.038026,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.173433,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":5,"adr":0,"listingDate":1607403600000,"exchange":"NASDAQ","adjPreClose":27.35,"preHourTrading":{"tag":"盘前","latestPrice":27.4,"preClose":27.35,"latestTime":"08:21 EDT","volume":282,"amount":7726.81974,"timestamp":1774614076068,"change":0.05,"changeRate":0.001828,"amplitude":0.000366},"postHourTrading":{"tag":"盘后","latestPrice":26,"preClose":26.52,"latestTime":"19:51 EDT","volume":60579,"amount":1603294.66,"timestamp":1774655502579,"change":-0.52,"changeRate":-0.019608,"amplitude":0.038462},"volumeRatio":0.383205,"impliedVol":0.3238,"impliedVolPercentile":0.4223},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ROIV\",,,,,undefined,":{"symbol":"ROIV","floatShares":467000000,"roa":"-14.47%","roe":"-19.14%","lyrEps":-0.237085,"volumeRatio":0.383205,"shares":715701137,"dividePrice":0,"high":27.51,"amplitude":0.038026,"preClose":27.35,"low":26.47,"week52Low":8.73,"pbRate":"4.45","psRate":"1426.03","week52High":30.33,"institutionHeld":0,"latestPrice":26.52,"eps":-1.173433,"divideRate":0,"volume":3011878,"delay":0,"ttmEps":-1.173433,"open":27.26,"prevYearClose":21.7,"prevWeekClose":27.7,"prevMonthClose":28.94,"prevQuarterClose":21.7,"fiveDayClose":27.7,"twentyDayClose":28.94,"sixtyDayClose":21.63},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ROIV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-06","symbol":"ROIV","fiscalQuarterEnding":"2025/12","expectedEps":-0.38,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1770354000000,"reportTimeType":"pre","actualEps":-0.2},{"market":"US","date":"2025-11-10","symbol":"ROIV","fiscalQuarterEnding":"2025/09","expectedEps":-0.34,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":-0.4},{"market":"US","date":"2025-08-11","symbol":"ROIV","fiscalQuarterEnding":"2025/06","expectedEps":-0.31,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-0.3},{"market":"US","date":"2025-05-29","symbol":"ROIV","fiscalQuarterEnding":"2025/03","expectedEps":-0.23,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1748491200000,"reportTimeType":"pre","actualEps":-0.31},{"market":"US","date":"2025-02-10","symbol":"ROIV","fiscalQuarterEnding":"2024/12","expectedEps":-0.3,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1739163600000,"reportTimeType":"pre","actualEps":-0.2}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ROIV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ROIV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4615,"buy":0.4615,"hold":0.0769,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4615,"analysts":13,"updateTime":1773979200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ROIV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ROIV","date":"2026-03-26","current":-22.600353,"percent":0.215105,"low":-71.097356,"twenty":-25.025307,"median":-4.997594,"eighty":1.694649,"high":2.128992,"avg":-13.382286,"sd":19.452125,"marketCap":19581583108},"quantilePoints":[{"date":"2021-10-01","current":-7.393592,"twenty":-7.393592,"median":-7.393592,"eighty":-7.393592,"marketCap":6566796009},{"date":"2021-10-08","current":-5.068762,"twenty":-7.200647,"median":-5.392973,"eighty":-5.011828,"marketCap":4501942504},{"date":"2021-10-15","current":-4.760366,"twenty":-6.226432,"median":-5.064808,"eighty":-4.897958,"marketCap":4228033366},{"date":"2021-10-22","current":-5.377158,"twenty":-5.411951,"median":-4.997594,"eighty":-4.833116,"marketCap":4775851643},{"date":"2021-10-29","current":-6.278622,"twenty":-6.291275,"median":-5.22296,"eighty":-4.848931,"marketCap":5576509124},{"date":"2021-11-05","current":-6.120471,"twenty":-6.278622,"median":-5.416696,"eighty":-4.897958,"marketCap":5436042899},{"date":"2021-11-12","current":-6.642371,"twenty":-6.291275,"median":-5.970226,"eighty":-4.945404,"marketCap":5899581441},{"date":"2021-11-19","current":-5.294334,"twenty":-6.278622,"median":-5.426692,"eighty":-4.965964,"marketCap":5618648992},{"date":"2021-11-26","current":-4.632542,"twenty":-6.278622,"median":-5.392973,"eighty":-4.942241,"marketCap":4916317868},{"date":"2021-12-03","current":-5.94289,"twenty":-6.246992,"median":-5.404834,"eighty":-4.886887,"marketCap":6306933493},{"date":"2021-12-10","current":-5.9098,"twenty":-6.278622,"median":-5.56694,"eighty":-4.942241,"marketCap":6271816937},{"date":"2021-12-17","current":-7.24662,"twenty":-6.278622,"median":-5.70859,"eighty":-4.958056,"marketCap":7690525807},{"date":"2021-12-23","current":-7.915029,"twenty":-6.461382,"median":-5.896565,"eighty":-4.962362,"marketCap":8399880243},{"date":"2021-12-31","current":-6.670861,"twenty":-6.679397,"median":-5.936272,"eighty":-4.990763,"marketCap":7079497729},{"date":"2022-01-07","current":-5.658319,"twenty":-6.654395,"median":-5.93348,"eighty":-5.048202,"marketCap":6004931110},{"date":"2022-01-14","current":-5.261244,"twenty":-6.643953,"median":-5.883329,"eighty":-5.051959,"marketCap":5583532435},{"date":"2022-01-21","current":-4.79799,"twenty":-6.611816,"median":-5.850239,"eighty":-4.961285,"marketCap":5091900649},{"date":"2022-01-28","current":-4.420769,"twenty":-6.571592,"median":-5.612629,"eighty":-4.867909,"marketCap":4691571908},{"date":"2022-02-04","current":-4.718575,"twenty":-6.480662,"median":-5.4664,"eighty":-4.79799,"marketCap":5007620914},{"date":"2022-02-11","current":-4.533273,"twenty":-6.411262,"median":-5.421694,"eighty":-4.75404,"marketCap":4810968199},{"date":"2022-02-18","current":-4.229896,"twenty":-6.336473,"median":-5.386985,"eighty":-4.697398,"marketCap":4588438579},{"date":"2022-02-25","current":-4.197996,"twenty":-6.294119,"median":-5.373749,"eighty":-4.638618,"marketCap":4553834970},{"date":"2022-03-04","current":-3.611042,"twenty":-6.287633,"median":-5.300952,"eighty":-4.614157,"marketCap":3917128561},{"date":"2022-03-11","current":-3.209106,"twenty":-6.278622,"median":-5.214919,"eighty":-4.599453,"marketCap":3481123085},{"date":"2022-03-18","current":-3.311185,"twenty":-6.26597,"median":-5.064808,"eighty":-4.551803,"marketCap":3591854634},{"date":"2022-03-25","current":-3.177207,"twenty":-6.224851,"median":-4.997594,"eighty":-4.245208,"marketCap":3446519476},{"date":"2022-04-01","current":-3.087888,"twenty":-6.188476,"median":-4.960747,"eighty":-4.132921,"marketCap":3349629370},{"date":"2022-04-08","current":-2.647672,"twenty":-6.180568,"median":-4.886887,"eighty":-3.804992,"marketCap":2872099563},{"date":"2022-04-14","current":-2.580683,"twenty":-6.166298,"median":-4.831534,"eighty":-3.511515,"marketCap":2799431984},{"date":"2022-04-22","current":-2.494554,"twenty":-6.126648,"median":-4.804608,"eighty":-3.330325,"marketCap":2706002239},{"date":"2022-04-29","current":-2.354195,"twenty":-6.120471,"median":-4.79799,"eighty":-3.283114,"marketCap":2553746358},{"date":"2022-05-06","current":-2.309536,"twenty":-6.09833,"median":-4.74149,"eighty":-3.183587,"marketCap":2505301306},{"date":"2022-05-13","current":-2.207457,"twenty":-5.999036,"median":-4.718575,"eighty":-3.099372,"marketCap":2394569756},{"date":"2022-05-20","current":-2.360575,"twenty":-5.953479,"median":-4.649087,"eighty":-2.763787,"marketCap":2560667080},{"date":"2022-05-27","current":-2.577493,"twenty":-5.941566,"median":-4.632542,"eighty":-2.637464,"marketCap":2795971623},{"date":"2022-06-03","current":-2.781651,"twenty":-5.936272,"median":-4.625924,"eighty":-2.634912,"marketCap":3017434722},{"date":"2022-06-10","current":-2.469034,"twenty":-5.930689,"median":-4.602882,"eighty":-2.583873,"marketCap":2678319352},{"date":"2022-06-17","current":-2.794411,"twenty":-5.9098,"median":-4.599453,"eighty":-2.577493,"marketCap":3031276165},{"date":"2022-06-24","current":-3.055988,"twenty":-5.888623,"median":-4.592835,"eighty":-2.577493,"marketCap":3315025761},{"date":"2022-07-01","current":-3.664409,"twenty":-5.883329,"median":-4.477021,"eighty":-2.580045,"marketCap":3097385357},{"date":"2022-07-08","current":-4.01261,"twenty":-5.863475,"median":-4.327927,"eighty":-2.582597,"marketCap":3391707043},{"date":"2022-07-15","current":-3.540051,"twenty":-5.794648,"median":-4.223516,"eighty":-2.595357,"marketCap":2992270469},{"date":"2022-07-22","current":-3.564922,"twenty":-5.698027,"median":-4.143766,"eighty":-2.610669,"marketCap":3013293447},{"date":"2022-07-29","current":-3.311167,"twenty":-5.603492,"median":-4.012978,"eighty":-2.627256,"marketCap":2798803556},{"date":"2022-08-05","current":-3.136457,"twenty":-5.546323,"median":-3.998124,"eighty":-2.642568,"marketCap":2651127991},{"date":"2022-08-12","current":-3.635628,"twenty":-5.492872,"median":-3.896543,"eighty":-2.647672,"marketCap":3073058176},{"date":"2022-08-19","current":-2.37779,"twenty":-5.442575,"median":-3.739024,"eighty":-2.627256,"marketCap":2603414024},{"date":"2022-08-26","current":-2.409923,"twenty":-5.426692,"median":-3.722442,"eighty":-2.582597,"marketCap":2638595295},{"date":"2022-09-02","current":-2.262114,"twenty":-5.420694,"median":-3.686206,"eighty":-2.571113,"marketCap":2476761450},{"date":"2022-09-09","current":-2.319952,"twenty":-5.407207,"median":-3.656118,"eighty":-2.54405,"marketCap":2540087737},{"date":"2022-09-16","current":-2.0886,"twenty":-5.390578,"median":-3.622956,"eighty":-2.522626,"marketCap":2286782589},{"date":"2022-09-23","current":-1.923582,"twenty":-5.383054,"median":-3.581602,"eighty":-2.479242,"marketCap":2106106321},{"date":"2022-09-30","current":-2.071549,"twenty":-5.375794,"median":-3.540051,"eighty":-2.458826,"marketCap":2268114499},{"date":"2022-10-07","current":-2.830689,"twenty":-5.36316,"median":-3.496169,"eighty":-2.456274,"marketCap":3099286894},{"date":"2022-10-14","current":-2.946489,"twenty":-5.331394,"median":-3.460918,"eighty":-2.458826,"marketCap":3226075903},{"date":"2022-10-21","current":-2.856422,"twenty":-5.302276,"median":-3.442407,"eighty":-2.462654,"marketCap":3127462229},{"date":"2022-10-28","current":-3.377526,"twenty":-5.281098,"median":-3.377526,"eighty":-2.464697,"marketCap":3698012771},{"date":"2022-11-04","current":-3.538361,"twenty":-5.242714,"median":-3.39361,"eighty":-2.46827,"marketCap":3874108617},{"date":"2022-11-11","current":-3.413882,"twenty":-5.212272,"median":-3.409693,"eighty":-2.479242,"marketCap":3737818266},{"date":"2022-11-18","current":-3.079035,"twenty":-5.152485,"median":-3.375884,"eighty":-2.494554,"marketCap":3627093935},{"date":"2022-11-25","current":-3.177564,"twenty":-5.06718,"median":-3.35355,"eighty":-2.494554,"marketCap":3743160940},{"date":"2022-12-02","current":-3.879584,"twenty":-5.051959,"median":-3.352764,"eighty":-2.499658,"marketCap":4570138358},{"date":"2022-12-09","current":-4.310649,"twenty":-5.012624,"median":-3.375884,"eighty":-2.52135,"marketCap":5077931509},{"date":"2022-12-16","current":-4.507707,"twenty":-4.994734,"median":-3.411571,"eighty":-2.52773,"marketCap":5310065520},{"date":"2022-12-23","current":-4.316807,"twenty":-4.979321,"median":-3.429759,"eighty":-2.532833,"marketCap":5085185696},{"date":"2022-12-30","current":-4.920298,"twenty":-4.963438,"median":-3.442407,"eighty":-2.532833,"marketCap":5796096108},{"date":"2023-01-06","current":-5.696215,"twenty":-4.986152,"median":-3.459421,"eighty":-2.537937,"marketCap":6710123779},{"date":"2023-01-13","current":-6.078015,"twenty":-5.062436,"median":-3.489823,"eighty":-2.548887,"marketCap":7159883427},{"date":"2023-01-20","current":-5.406785,"twenty":-5.233449,"median":-3.502516,"eighty":-2.555534,"marketCap":6369176949},{"date":"2023-01-27","current":-5.26515,"twenty":-5.262806,"median":-3.539206,"eighty":-2.566009,"marketCap":6202330628},{"date":"2023-02-03","current":-4.803295,"twenty":-5.259893,"median":-3.564922,"eighty":-2.571113,"marketCap":5658266538},{"date":"2023-02-10","current":-5.115464,"twenty":-5.244212,"median":-3.604662,"eighty":-2.574941,"marketCap":6026001052},{"date":"2023-02-17","current":-5.249117,"twenty":-5.262806,"median":-3.622956,"eighty":-2.577493,"marketCap":6537643757},{"date":"2023-02-24","current":-4.707155,"twenty":-5.260343,"median":-3.647828,"eighty":-2.578769,"marketCap":5862643415},{"date":"2023-03-03","current":-4.902017,"twenty":-5.255042,"median":-3.686206,"eighty":-2.581959,"marketCap":6105340167},{"date":"2023-03-10","current":-4.658439,"twenty":-5.243214,"median":-3.722442,"eighty":-2.58884,"marketCap":5801969227},{"date":"2023-03-17","current":-5.297833,"twenty":-5.243214,"median":-3.739024,"eighty":-2.598979,"marketCap":6598317945},{"date":"2023-03-24","current":-4.213908,"twenty":-5.243214,"median":-3.8468,"eighty":-2.606589,"marketCap":5248317262},{"date":"2023-03-31","current":-4.494023,"twenty":-5.232955,"median":-3.897301,"eighty":-2.613481,"marketCap":5597193843},{"date":"2023-04-06","current":-4.329608,"twenty":-5.228412,"median":-3.950432,"eighty":-2.619601,"marketCap":5392418458},{"date":"2023-04-14","current":-4.627992,"twenty":-5.217919,"median":-4.01261,"eighty":-2.637464,"marketCap":5764047860},{"date":"2023-04-21","current":-5.358727,"twenty":-5.233657,"median":-4.051523,"eighty":-2.647672,"marketCap":6674160680},{"date":"2023-04-28","current":-5.133417,"twenty":-5.258992,"median":-4.076932,"eighty":-2.647672,"marketCap":6393542560},{"date":"2023-05-05","current":-5.115149,"twenty":-5.249117,"median":-4.210756,"eighty":-2.654052,"marketCap":6370789740},{"date":"2023-05-12","current":-5.510964,"twenty":-5.261296,"median":-4.226706,"eighty":-2.654128,"marketCap":6863767517},{"date":"2023-05-19","current":-5.535322,"twenty":-5.302098,"median":-4.268175,"eighty":-2.724231,"marketCap":6894104611},{"date":"2023-05-26","current":-5.620574,"twenty":-5.32219,"median":-4.304491,"eighty":-2.730611,"marketCap":7000284440},{"date":"2023-05-31","current":-5.523143,"twenty":-5.32219,"median":-4.313728,"eighty":-2.730611,"marketCap":6878936064},{"date":"2023-06-09","current":-5.833705,"twenty":-5.36774,"median":-4.329608,"eighty":-2.730865,"marketCap":7265734013},{"date":"2023-06-16","current":-6.040747,"twenty":-5.386985,"median":-4.34784,"eighty":-2.731246,"marketCap":7523599312},{"date":"2023-06-23","current":-6.071194,"twenty":-5.402439,"median":-4.369153,"eighty":-2.743893,"marketCap":7561520679},{"date":"2023-06-30","current":-7.523496,"twenty":-5.414714,"median":-4.379957,"eighty":-2.752698,"marketCap":7591433186},{"date":"2023-07-07","current":-8.093458,"twenty":-5.42245,"median":-4.39535,"eighty":-2.763985,"marketCap":8166541761},{"date":"2023-07-10","current":-8.20745,"twenty":-5.426692,"median":-4.40302,"eighty":-2.769628,"marketCap":8281563476},{"date":"2023-07-21","current":-8.458233,"twenty":-5.426692,"median":-4.411894,"eighty":-2.775271,"marketCap":8534611249},{"date":"2023-07-28","current":-8.20745,"twenty":-5.456159,"median":-4.423904,"eighty":-2.776851,"marketCap":8281563476},{"date":"2023-08-02","current":-9.084475,"twenty":-5.504874,"median":-4.43381,"eighty":-2.779221,"marketCap":9166507826},{"date":"2023-08-11","current":-8.673275,"twenty":-5.533128,"median":-4.451397,"eighty":-2.781165,"marketCap":8751594647},{"date":"2023-08-17","current":-8.609097,"twenty":-5.568907,"median":-4.464601,"eighty":-2.789307,"marketCap":8342533149},{"date":"2023-08-25","current":-8.848017,"twenty":-5.635672,"median":-4.494023,"eighty":-2.794411,"marketCap":8574055808},{"date":"2023-09-01","current":-9.214361,"twenty":-5.70006,"median":-4.494023,"eighty":-2.796878,"marketCap":8929057219},{"date":"2023-09-08","current":-9.317894,"twenty":-5.725205,"median":-4.506954,"eighty":-2.804955,"marketCap":9029383704},{"date":"2023-09-15","current":-9.150649,"twenty":-5.757588,"median":-4.518382,"eighty":-2.830689,"marketCap":8867317843},{"date":"2023-09-19","current":-8.855981,"twenty":-5.782386,"median":-4.524471,"eighty":-2.831089,"marketCap":8581773230},{"date":"2023-10-05","current":-7.985677,"twenty":-5.795976,"median":-4.528872,"eighty":-2.831489,"marketCap":7738416687},{"date":"2023-10-09","current":-8.819584,"twenty":-5.801844,"median":-4.533273,"eighty":-2.83189,"marketCap":8546503125},{"date":"2023-11-10","current":-6.982171,"twenty":-5.878767,"median":-4.593193,"eighty":-2.839209,"marketCap":6765981641},{"date":"2023-11-17","current":-7.385988,"twenty":-5.911027,"median":-4.599453,"eighty":-2.843555,"marketCap":7251370631},{"date":"2023-11-24","current":-7.476061,"twenty":-5.936844,"median":-4.606312,"eighty":-2.848702,"marketCap":7339801980},{"date":"2023-12-01","current":-7.828164,"twenty":-5.955617,"median":-4.626958,"eighty":-2.858995,"marketCap":7685488163},{"date":"2023-12-08","current":-7.983745,"twenty":-6.044634,"median":-4.632542,"eighty":-2.865429,"marketCap":7838233221},{"date":"2023-12-15","current":-9.113752,"twenty":-6.115375,"median":-4.64756,"eighty":-2.880169,"marketCap":8947644692},{"date":"2023-12-22","current":-8.630633,"twenty":-6.163796,"median":-4.652396,"eighty":-2.903623,"marketCap":8473331092},{"date":"2023-12-29","current":-9.310275,"twenty":-6.191639,"median":-4.65697,"eighty":-2.914323,"marketCap":9140585817},{"date":"2024-01-05","current":-8.85991,"twenty":-6.278622,"median":-4.665632,"eighty":-2.914323,"marketCap":8698429071},{"date":"2024-01-12","current":-8.999114,"twenty":-6.411262,"median":-4.682797,"eighty":-2.933623,"marketCap":8835095702},{"date":"2024-01-19","current":-8.606068,"twenty":-6.622001,"median":-4.702881,"eighty":-2.951636,"marketCap":8449213451},{"date":"2024-01-26","current":-8.614256,"twenty":-6.787201,"median":-4.725193,"eighty":-2.964833,"marketCap":8457252665},{"date":"2024-02-02","current":-8.229399,"twenty":-7.069423,"median":-4.752459,"eighty":-2.973569,"marketCap":8079409627},{"date":"2024-02-09","current":-8.655198,"twenty":-7.254542,"median":-4.792407,"eighty":-2.978932,"marketCap":8497448732},{"date":"2024-02-16","current":2.065844,"twenty":-7.303922,"median":-4.780228,"eighty":-2.964833,"marketCap":9226936768},{"date":"2024-02-23","current":2.049606,"twenty":-7.257183,"median":-4.752459,"eighty":-2.914323,"marketCap":9154410628},{"date":"2024-03-01","current":2.06404,"twenty":-7.238464,"median":-4.725193,"eighty":-2.857709,"marketCap":9218878308},{"date":"2024-03-08","current":2.011717,"twenty":-7.203572,"median":-4.702881,"eighty":-2.831089,"marketCap":8985182966},{"date":"2024-03-15","current":1.845728,"twenty":-7.17056,"median":-4.682797,"eighty":-2.784203,"marketCap":8243804641},{"date":"2024-03-22","current":1.851141,"twenty":-7.072124,"median":-4.662035,"eighty":-2.734408,"marketCap":8267980021},{"date":"2024-03-28","current":1.955786,"twenty":-7.061318,"median":-4.653949,"eighty":-2.724231,"marketCap":8735370705},{"date":"2024-04-05","current":2.07667,"twenty":-7.041464,"median":-4.649343,"eighty":-2.647672,"marketCap":9275287529},{"date":"2024-04-12","current":2.015326,"twenty":-6.982171,"median":-4.633193,"eighty":-2.603013,"marketCap":9001299887},{"date":"2024-04-19","current":1.869183,"twenty":-6.836309,"median":-4.627992,"eighty":-2.577493,"marketCap":8348564622},{"date":"2024-04-26","current":1.963003,"twenty":-6.71354,"median":-4.606312,"eighty":-2.558353,"marketCap":8767604545},{"date":"2024-05-03","current":2.027955,"twenty":-6.670861,"median":-4.599453,"eighty":-2.532833,"marketCap":9057709107},{"date":"2024-05-10","current":2.02976,"twenty":-6.650279,"median":-4.593193,"eighty":-2.494554,"marketCap":9065767567},{"date":"2024-05-17","current":2.058627,"twenty":-6.642371,"median":-4.533273,"eighty":-2.462654,"marketCap":9194702928},{"date":"2024-05-24","current":1.973829,"twenty":-6.591446,"median":-4.51,"eighty":-2.454908,"marketCap":8815955305},{"date":"2024-05-31","current":1.718448,"twenty":-6.564974,"median":-4.500113,"eighty":-2.434582,"marketCap":7675319574},{"date":"2024-06-07","current":1.803946,"twenty":-6.454764,"median":-4.494023,"eighty":-2.405157,"marketCap":7845225590},{"date":"2024-06-14","current":1.83622,"twenty":-6.411262,"median":-4.475755,"eighty":-2.37522,"marketCap":7985582733},{"date":"2024-06-21","current":1.834521,"twenty":-6.357491,"median":-4.458443,"eighty":-2.36232,"marketCap":7978195515},{"date":"2024-06-28","current":1.795452,"twenty":-6.315456,"median":-4.451397,"eighty":-2.359299,"marketCap":7808289499},{"date":"2024-07-05","current":1.780165,"twenty":-6.293959,"median":-4.43381,"eighty":-2.336521,"marketCap":7741804537},{"date":"2024-07-12","current":1.909261,"twenty":-6.284629,"median":-4.411894,"eighty":-2.31496,"marketCap":8303233110},{"date":"2024-07-15","current":1.927946,"twenty":-6.281626,"median":-4.40302,"eighty":-2.312728,"marketCap":8384492509},{"date":"2024-08-02","current":1.805074,"twenty":-6.278622,"median":-4.39535,"eighty":-2.309536,"marketCap":7850132402},{"date":"2024-08-09","current":1.693429,"twenty":-6.278622,"median":-4.366072,"eighty":-2.252116,"marketCap":8020144685},{"date":"2024-08-16","current":1.766031,"twenty":-6.246992,"median":-4.329608,"eighty":-2.236408,"marketCap":8363991829},{"date":"2024-08-23","current":1.823806,"twenty":-6.191639,"median":-4.316807,"eighty":-2.107879,"marketCap":8637614904},{"date":"2024-08-30","current":1.876896,"twenty":-6.183731,"median":-4.292175,"eighty":-2.071549,"marketCap":8889052324},{"date":"2024-09-06","current":1.903441,"twenty":-6.177405,"median":-4.262355,"eighty":-2.013004,"marketCap":9014771034},{"date":"2024-09-13","current":1.892511,"twenty":-6.151768,"median":-4.223516,"eighty":-1.918435,"marketCap":8963004506},{"date":"2024-09-20","current":1.861281,"twenty":-6.131704,"median":-4.204376,"eighty":1.697441,"marketCap":8815100142},{"date":"2024-09-27","current":1.806629,"twenty":-6.122015,"median":-4.064326,"eighty":1.738237,"marketCap":8556267503},{"date":"2024-10-04","current":1.750416,"twenty":-6.120471,"median":-4.028928,"eighty":1.751704,"marketCap":8290039647},{"date":"2024-10-11","current":1.853474,"twenty":-6.110279,"median":-4.000218,"eighty":1.762284,"marketCap":8778124050},{"date":"2024-10-18","current":1.85972,"twenty":-6.083958,"median":-3.901446,"eighty":1.777262,"marketCap":8807704923},{"date":"2024-10-25","current":1.842543,"twenty":-6.072558,"median":-3.879584,"eighty":1.781575,"marketCap":8726357523},{"date":"2024-10-31","current":1.83942,"twenty":-6.056813,"median":-3.805687,"eighty":1.791991,"marketCap":8711567086},{"date":"2024-11-08","current":1.836298,"twenty":-6.043338,"median":-3.726587,"eighty":1.795307,"marketCap":8696776650},{"date":"2024-11-15","current":1.761541,"twenty":-6.022157,"median":-3.710504,"eighty":1.796132,"marketCap":8473335020},{"date":"2024-11-22","current":1.788782,"twenty":-5.980856,"median":-3.669625,"eighty":1.795452,"marketCap":8604365974},{"date":"2024-11-29","current":1.92347,"twenty":-5.959401,"median":-3.641728,"eighty":1.799135,"marketCap":9252241246},{"date":"2024-12-06","current":1.828129,"twenty":-5.955617,"median":-3.621995,"eighty":1.805651,"marketCap":8793632907},{"date":"2024-12-13","current":1.797862,"twenty":-5.950068,"median":-3.584982,"eighty":1.808349,"marketCap":8648042958},{"date":"2024-12-20","current":1.740355,"twenty":-5.940624,"median":-3.556632,"eighty":1.808807,"marketCap":8371422056},{"date":"2024-12-27","current":1.816022,"twenty":-5.937226,"median":-3.538361,"eighty":1.814437,"marketCap":8735396928},{"date":"2025-01-03","current":1.828129,"twenty":-5.937226,"median":-3.502516,"eighty":1.814437,"marketCap":8793632907},{"date":"2025-01-10","current":1.667714,"twenty":-5.936463,"median":-3.489823,"eighty":1.814437,"marketCap":8022006178},{"date":"2025-01-17","current":1.64804,"twenty":-5.931806,"median":-3.459421,"eighty":1.81012,"marketCap":7927372712},{"date":"2025-01-24","current":1.696467,"twenty":-5.919996,"median":-3.442407,"eighty":1.808689,"marketCap":8160316630},{"date":"2025-01-31","current":1.720681,"twenty":-5.911027,"median":-3.427114,"eighty":1.808297,"marketCap":8276788589},{"date":"2025-02-07","current":1.645013,"twenty":-5.893917,"median":-3.410632,"eighty":1.807254,"marketCap":7912813717},{"date":"2025-02-14","current":-63.938672,"twenty":-5.936654,"median":-3.427114,"eighty":1.806273,"marketCap":7456591836},{"date":"2025-02-21","current":-65.590676,"twenty":-5.950068,"median":-3.43596,"eighty":1.805651,"marketCap":7649250189},{"date":"2025-02-28","current":-63.510374,"twenty":-6.028354,"median":-3.459421,"eighty":1.804623,"marketCap":7406643374},{"date":"2025-03-07","current":-64.856452,"twenty":-6.095845,"median":-3.489823,"eighty":1.803146,"marketCap":7563624254},{"date":"2025-03-14","current":-63.755116,"twenty":-6.138729,"median":-3.504703,"eighty":1.801321,"marketCap":7435185352},{"date":"2025-03-21","current":-67.120309,"twenty":-6.224851,"median":-3.540051,"eighty":1.799375,"marketCap":7827637554},{"date":"2025-03-28","current":-64.122228,"twenty":-6.294119,"median":-3.568302,"eighty":1.797622,"marketCap":7477998319},{"date":"2025-04-04","current":-61.246517,"twenty":-6.57821,"median":-3.611042,"eighty":1.797217,"marketCap":7142630074},{"date":"2025-04-11","current":-59.043845,"twenty":-6.696468,"median":-3.629292,"eighty":1.796471,"marketCap":6885752269},{"date":"2025-04-17","current":-61.307702,"twenty":-7.029605,"median":-3.656118,"eighty":1.795452,"marketCap":7149765569},{"date":"2025-04-25","current":-67.303865,"twenty":-7.203572,"median":-3.697571,"eighty":1.795404,"marketCap":7849044038},{"date":"2025-05-02","current":-70.852614,"twenty":-7.3427,"median":-3.722442,"eighty":1.794996,"marketCap":8262902723},{"date":"2025-05-09","current":-67.487421,"twenty":-7.407161,"median":-3.747314,"eighty":1.793826,"marketCap":7870450521},{"date":"2025-05-16","current":-65.835417,"twenty":-7.440032,"median":-3.863192,"eighty":1.792576,"marketCap":7677792168},{"date":"2025-05-23","current":-66.936753,"twenty":-7.514009,"median":-3.898058,"eighty":1.792422,"marketCap":7806231070},{"date":"2025-05-30","current":-44.666612,"twenty":-7.615264,"median":-3.996029,"eighty":1.791808,"marketCap":7681808591},{"date":"2025-06-06","current":-44.271332,"twenty":-7.828164,"median":-4.012794,"eighty":1.791601,"marketCap":7613827984},{"date":"2025-06-13","current":-45.338588,"twenty":-7.985677,"median":-4.058168,"eighty":1.790295,"marketCap":7797375622},{"date":"2025-06-20","current":-45.220004,"twenty":-8.052528,"median":-4.089537,"eighty":1.789085,"marketCap":7776981440},{"date":"2025-06-27","current":-45.852451,"twenty":-8.132775,"median":-4.212332,"eighty":1.786858,"marketCap":7885750412},{"date":"2025-07-03","current":-43.441245,"twenty":-8.195007,"median":-4.226706,"eighty":1.786004,"marketCap":7471068709},{"date":"2025-07-11","current":-45.733867,"twenty":-8.236009,"median":-4.268175,"eighty":1.785163,"marketCap":7865356229},{"date":"2025-07-18","current":-46.050091,"twenty":-8.440661,"median":-4.304491,"eighty":1.782373,"marketCap":7919740715},{"date":"2025-07-25","current":-44.982836,"twenty":-8.475052,"median":-4.317429,"eighty":1.780409,"marketCap":7736193076},{"date":"2025-08-01","current":-44.90378,"twenty":-8.532372,"median":-4.34784,"eighty":1.780165,"marketCap":7722596955},{"date":"2025-08-08","current":-45.837033,"twenty":-8.611161,"median":-4.372234,"eighty":1.779146,"marketCap":7883098769},{"date":"2025-08-15","current":-16.34542,"twenty":-8.663439,"median":-4.411894,"eighty":1.777563,"marketCap":8019602644},{"date":"2025-08-22","current":-16.428886,"twenty":-8.766224,"median":-4.43381,"eighty":1.776024,"marketCap":8060553806},{"date":"2025-08-29","current":-16.618548,"twenty":-8.845327,"median":-4.45492,"eighty":1.774463,"marketCap":8153608011},{"date":"2025-09-05","current":-17.495406,"twenty":-8.854277,"median":-4.470178,"eighty":1.771946,"marketCap":8583823509},{"date":"2025-09-12","current":-20.056388,"twenty":-8.876687,"median":-4.494023,"eighty":1.769108,"marketCap":9840325916},{"date":"2025-09-19","current":-21.002838,"twenty":-8.897577,"median":-4.500113,"eighty":1.767877,"marketCap":10304685501},{"date":"2025-09-26","current":-20.821899,"twenty":-8.942703,"median":-4.512292,"eighty":1.764235,"marketCap":10215910875},{"date":"2025-10-03","current":-22.241574,"twenty":-9.033505,"median":-4.556436,"eighty":1.761541,"marketCap":10912450253},{"date":"2025-10-10","current":-22.436432,"twenty":-9.13201,"median":-4.593552,"eighty":1.761463,"marketCap":11008053697},{"date":"2025-10-17","current":-24.093621,"twenty":-9.171002,"median":-4.599453,"eighty":1.761347,"marketCap":11821125436},{"date":"2025-10-24","current":-25.515863,"twenty":-9.267695,"median":-4.606312,"eighty":1.759121,"marketCap":12518924190},{"date":"2025-10-31","current":-27.571776,"twenty":-9.314846,"median":-4.630267,"eighty":1.753849,"marketCap":13527623380},{"date":"2025-11-07","current":-28.965855,"twenty":-9.38078,"median":-4.633845,"eighty":1.750842,"marketCap":14211604337},{"date":"2025-11-14","current":-38.236714,"twenty":-16.050507,"median":-4.650846,"eighty":1.750577,"marketCap":14299307604},{"date":"2025-11-21","current":-37.697383,"twenty":-16.342611,"median":-4.655501,"eighty":1.750416,"marketCap":14097615036},{"date":"2025-11-28","current":-38.701655,"twenty":-16.456526,"median":-4.665632,"eighty":1.749791,"marketCap":14473180508},{"date":"2025-12-05","current":-39.389767,"twenty":-16.615764,"median":-4.682797,"eighty":1.746981,"marketCap":14730512405},{"date":"2025-12-12","current":-39.687329,"twenty":-17.4453,"median":-4.707155,"eighty":1.745262,"marketCap":14841791064},{"date":"2025-12-19","current":-40.524222,"twenty":-18.606093,"median":-4.731811,"eighty":1.743078,"marketCap":15154762290},{"date":"2025-12-26","current":-41.844653,"twenty":-19.597082,"median":-4.752459,"eighty":1.741868,"marketCap":15648561337},{"date":"2026-01-02","current":-40.356843,"twenty":-20.471156,"median":-4.780228,"eighty":1.740658,"marketCap":15092168045},{"date":"2026-01-09","current":-40.505624,"twenty":-20.947164,"median":-4.79799,"eighty":1.739144,"marketCap":15147807374},{"date":"2026-01-16","current":-43.332463,"twenty":-21.144805,"median":-4.80726,"eighty":1.736859,"marketCap":16204954629},{"date":"2026-01-23","current":-42.718742,"twenty":-22.269411,"median":-4.820349,"eighty":1.732402,"marketCap":15975442396},{"date":"2026-01-30","current":-40.951967,"twenty":-22.464268,"median":-4.839442,"eighty":1.729057,"marketCap":15314725362},{"date":"2026-02-06","current":-39.315377,"twenty":-23.265544,"median":-4.869723,"eighty":1.723844,"marketCap":14702692741},{"date":"2026-02-13","current":-23.658007,"twenty":-23.992234,"median":-4.895928,"eighty":1.719341,"marketCap":19145005414},{"date":"2026-02-20","current":-24.339004,"twenty":-24.150641,"median":-4.920298,"eighty":1.716464,"marketCap":19696095290},{"date":"2026-02-27","current":-25.196883,"twenty":-24.32534,"median":-4.934107,"eighty":1.712733,"marketCap":20390325393},{"date":"2026-03-06","current":-26.284709,"twenty":-24.763521,"median":-4.942241,"eighty":1.709179,"marketCap":21270637791},{"date":"2026-03-13","current":-25.249947,"twenty":-25.183659,"median":-4.969264,"eighty":1.701915,"marketCap":20433267461},{"date":"2026-03-20","current":-24.586639,"twenty":-25.109832,"median":-4.983292,"eighty":1.695862,"marketCap":19896491608},{"date":"2026-03-26","current":-24.197498,"twenty":-25.025307,"median":-4.997594,"eighty":1.694649,"marketCap":19581583108}],"updateTime":1774663885818},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ROIV\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609591174","title":"Wall Street Set to Open Modestly Higher Friday as Tech Stocks Stabilize Following Week-Long Rout","url":"https://stock-news.laohu8.com/highlight/detail?id=2609591174","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609591174?lang=en_us&edition=fundamental","pubTime":"2026-02-06 22:11","pubTimestamp":1770387098,"startTime":"0","endTime":"0","summary":"US equities look set to open slightly higher in Friday's trading session with tech stocks rebounding modestly following a week-long rout, as stocks such as NVIDIA (NVDA), Microsoft (MSFT), and Tesla (","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SG9999017495.SGD","LU2506952097.USD","SG9999002224.SGD","MSFO","LU2413666699.HKD","IE00BJJMRY28.SGD","LU1989772923.USD","IE00BQXX3D17.EUR","IE0005OL40V9.USD","IE00BDRTCR15.USD","LU0426417589.USD","LU0310800379.SGD","LU1712237335.SGD","LU2360032135.SGD","LU0171293334.USD","SPXS","LU0823421416.USD","LU1923622614.USD","BK4588","IE000YTNTUN2.SGD","LU0724617625.USD","HK0000306701.USD","BK4598","IE000KEQY171.SGD","BK4574","LU2237443549.SGD","LU1670711040.USD","LU2381873111.SGD","LU1823568750.SGD","LU2458330169.SGD","CRSH","LU0545562505.USD","LU1629891620.HKD","LU0310799852.SGD","LU0323591593.USD","BK4534","LU0689626769.HKD","LU1923623000.USD","SG9999014559.SGD","LU1670710588.SGD","LU2111349929.HKD","IE00B775SV38.USD","HK0000320223.HKD","LU2471134952.CNY","LU0006306889.USD","SG9999014567.USD","2NVD.UK","LU2552382132.HKD","NVII","SG9999004303.SGD","USAW.SI","NVDS.UK","TSLA","GB00BDT5M118.USD","IE00BLSP4452.SGD","IE00B1BXHZ80.USD","IE00BMPRXN33.USD","LU1868837136.USD","LU0106261372.USD","LU0289960550.SGD","LU2077746001.SGD","SG9999001077.SGD","LU0889566641.SGD","LU0494093205.USD","LU0545039389.USD","LU1236620750.USD","LU0158827948.USD","BK4604","LU0308772762.SGD","LU1571399168.USD","TESL","LU1267930573.SGD","BK4579","LU0738911758.USD","LU0820562030.AUD","LU0203201768.USD","NVDA","LU0879622024.SGD","LU1069347547.HKD","LU1280957306.USD","LU2236285917.USD","BK4516","LU0345769631.USD","IE00B19Z8W00.USD","LU2097344357.USD","LU0097036916.USD","LU0950375773.USD","LU1116320737.USD","BK4139","LU0347712357.USD","LU0868494708.USD","SG9999015945.SGD","LU1221951129.SGD","STLA","LU2279689827.SGD","TSLG","SDOW","LU1732800096.USD","IE00BZ1G4Q59.USD","LU1582986433.USD","LU2089283258.USD","HK0000914660.USD","SNVD.UK","DOG","IE00B1XK9C88.USD","LU1861558580.USD","LU1868836914.USD","LU1778281490.HKD","LU0719512351.SGD","IE00BYXW3230.USD","LU0426412945.USD","LU0965508806.USD","LU1064131342.USD","LU2506951875.HKD","LU2357125470.USD","BK7104","IE00BJJMRX11.SGD","LU2506951792.HKD","LU2543165471.USD","IVW","BK4525","LU2430703178.SGD","LU0965509010.AUD","LU1430594728.SGD","LU2461242641.AUD","LU2491050071.SGD","LU1821325948.USD","LU1934455863.HKD","LU1585245621.USD","SG9999014005.SGD","IE00B3M56506.USD","LU1496350502.SGD","LU2108987350.USD","LU0640476718.USD","LU2420271590.USD","LU1988902786.USD","DXD","LU2092937221.SGD","LU0314106906.USD","IE00B5TLWC47.USD","LU1917777945.USD","BK4592","LU1923622291.USD","LU1815336760.USD","LU1564329461.SGD","LU2361045086.USD","LU1951200564.SGD","LU0316494557.USD","LU0345774631.USD","TSLT","LU0894486033.HKD","IE00B4JS1V06.HKD","LU1992135472.HKD","LU0957791311.USD","LU2413666426.HKD","SPLV","LU0795875086.SGD","LU2087625088.SGD","3NVD.UK","NVDW","TSLR","BK4614","LU0417517546.SGD","IE0003U64NQ7.SGD","LU0069063385.USD","BK4504","LU1868837300.USD","NVIW.SI","LU1267930813.SGD","PI","LU0096362180.USD","HK0000320264.USD","LU2168564149.EUR","LU0265550359.USD","IE00BJLML261.HKD","LU2092627202.USD","LU2125154778.USD","IE00B775H168.HKD","LU2764263039.SGD","BK4182","TQQQ","LU1242518931.SGD","LU2237443895.HKD","QYLD","LU1267930490.SGD","LU2506952170.USD","IE0034235295.USD","LU0345768740.USD","LU1366192091.USD","LU2473716301.USD","LU1221951046.USD","IE00BZ199S13.USD","LU2023250504.SGD","TSLS","LU1064927863.SGD","LU0289961442.SGD","LU2023250330.USD","LU2322448791.USD","LU2433249047.HKD","IE0001KFT4U8.USD","GB00B4LPDJ14.GBP","LU0234572021.USD","LU1989764664.SGD","LU1721428933.USD","LU1043141123.HKD","BK4566","IE00BFSS8Q28.SGD","LU1564329032.USD","LU1861220033.SGD","SG9999014542.SGD","LU0787776722.HKD","LU1037948541.HKD","LU2360107168.USD","LU0708995401.HKD","LU0162691827.USD","LU0861579265.USD","HK0000306685.HKD","LU0726765562.USD","LU2462157665.USD","LU2471134796.USD","LU1435385759.SGD","LU0912757837.SGD","BMAY","BK4503","IE00BK4W5L77.USD","LU1951198990.SGD","MNQmain","LU1674673691.USD","TSLW","LU0128525929.USD","LU0056508442.USD","LU0320765059.SGD","LU1116320901.HKD","IE00BHPRN162.USD","LU2860962120.EUR","LU1069344957.HKD","LU1429558221.USD","LU1732799900.SGD","LU2211815571.USD","SGXZ51526630.SGD","LU2250418816.HKD","BK4141","LU2491050154.USD","LU0157215616.USD","LU1074936037.SGD","BK4543","LU2237957902.USD","LU2125154935.USD","LU0029864427.USD","LU0210533765.USD","LU1983260115.SGD","LU1699723380.USD","LU2125909916.SGD","LU2106854487.HKD","IE00BWXC8680.SGD","LU1066051811.HKD","LU2089985449.USD","TSYY","BK4567","LU0444973449.USD","LU1003077747.HKD","PSQ","BK4555","LU1188199696.SGD","LU0170899867.USD","LU0323239441.USD","LU0251132253.USD","LU2244417387.USD","LU2213496289.HKD","LU0390134368.USD","LU0456855351.SGD","LU0466842654.USD","SG9999014013.SGD","LU1989764748.USD","LU1066051225.USD","LU0949170772.SGD","LU1670710661.SGD","IE00BFSS7M15.SGD","LU0109391861.USD","LU0198837287.USD","LU1564329115.USD","LU2264538146.SGD","LU0256863811.USD","LU0795875169.SGD","LU0823434740.USD","BK4541","NVD3.UK","LU1791710400.SGD","LU1861559042.SGD","IE00BQXX3C00.GBP","SGXZ31699556.SGD","LU2054465674.USD","BK4154","LU1718418525.SGD","ROIV","TSLY","LU0054578231.USD","LU2896262040.SGD","QQQY","BK4007","SG9999018857.SGD","BK4585","TSL","LU0690374961.EUR","LU1861215975.USD","USJW.SI","LU0077335932.USD","IE00BYQQ9H92.USD","NVDG","LU1551013342.USD","LU0683600562.USD","LU0289941410.SGD","LU1674673428.USD","SH","LU1196500208.SGD","LU2125909759.SGD","LU0187121727.USD","LU2756315664.SGD","VOO","LU0345774391.USD","BK4097","LU0276348264.USD","LU2097344431.USD","LU0788109477.HKD","LU2063271972.USD","LU1032466523.USD","GPIX","LU2931357623.SGD","LU0871640123.AUD","JEPQ","IE000ITXATA3.USD","LU2168563687.JPY","LU1506573853.SGD","LU1496350171.SGD","LU0238689110.USD","IE00BDCRKT87.USD","LU1814569148.SGD","SPYV","LU1066051498.USD","BK4608","LU0820561909.HKD","SG9999002232.USD","QYLG","SCHD","IE00B19Z8X17.USD","SGXZ23171101.USD","LU2471134523.USD","IE000W1ABFV2.USD","IE00BQXX3F31.USD","LU0210536198.USD","DIA","LU2347655073.USD","LU2272731782.SGD","LU1301847155.USD","LU1815333072.USD","LU2746668974.SGD","LU0107464264.USD","SG9999015952.SGD","LU0345768153.USD","LU1791710582.SGD","BK4577","MSFT","LU1623119135.USD","LU0979878070.USD","LU1803068623.USD","LU2065171402.SGD","SPDN","LU2552382058.USD","NVDQ","MSFY","HK0000914686.HKD","LU0823411888.USD","SQQQ","LU2237443622.USD","LU0823417737.USD","LU2237957811.SGD","LU1720051108.HKD","LU1316542783.SGD","IE00B5949003.HKD","LU0215105999.USD","LU0444971666.USD","QID","LU1035775433.USD","LU1974910355.USD","SPY","SG9999014575.USD","LU0323240290.USD","LU2456880835.USD","SG9999018865.SGD","SG9999014021.USD","LU1121112475.USD","LU0079474960.USD","BK4511","LU2491049909.HKD","BK4185","LU2097829019.USD","LU0094547139.USD","NVDY","UDOW","LU0792757196.USD","LU0210528500.USD","LU2750360641.GBP","LU2347655156.SGD","LU2168564222.USD","IVV","GB00B4QBRK32.GBP","LU0672654240.SGD","LU1935043536.SGD","LU0823421333.USD","LU1366333091.USD","SPXL","07766","LU2092937148.SGD","LU2275660780.HKD","LU0266013472.USD","LU1582986359.USD","LU0868494617.USD","LU1145028129.USD","LU0823414478.USD","LU2404859667.USD","LU0061474705.USD","SG9999014898.SGD","LU2487616109.SGD","BK4533","IE00BSNM7G36.USD","LU1551013425.SGD","LU2361044949.HKD","LU2471134879.HKD","SG9999014039.USD","LU0345769128.USD","LU1334329650.SGD","SG9999015341.SGD","LU2360108059.USD","LU2430703251.USD","LU1119994496.HKD","LU1839511570.USD","DIPS","LU0784385840.USD","LU2210149790.SGD","LU2505996681.GBP","LU0342679015.USD","LU0965509101.SGD","IE0004091025.USD","MYMmain","BK4532","LU2764263203.CNY","GPIQ","IE00BMPRXQ63.HKD","LU0061475181.USD","LU1582987597.SGD","LU2298321311.HKD","LU2756315318.SGD","SSO","LU2271345857.HKD","LU2750360997.AUD","LU0345770308.USD","IE0004086264.USD","NVDD","NVD","LU2133065610.SGD","LU0889565833.HKD","LU2463028550.USD","LU2403377893.USD","MSFD","LU2095319765.USD","TSLL","LU0689472784.USD","IE00BN29S564.USD","LU0158827781.USD","BK4548","SG9999001424.SGD","LU0757359954.USD","LU0354030511.USD","LU0823434583.USD","LU2065170008.USD","LU2087621335.USD","LU2326559502.SGD","LU2746668461.USD","LU1181866309.USD","LU2237443978.SGD","LU0943347566.SGD","LU1084165304.USD","LU2286300806.USD","LU0690374615.EUR","LU1878469433.USD","BK4587","BK4605","LU0274383776.USD","LU2452424414.USD","LU1066053197.SGD","LU1153585028.USD","LU0302445910.USD","LU2458330243.SGD","LU2720916845.USD","QQQE","LU0823414551.USD","IE00BJTD4N35.SGD","LU1228905037.USD","LU0472753341.HKD","LU2242650005.HKD","SPXU","LU0661504455.SGD","BK4550","LU1564329628.SGD","LU1046421795.USD","IE00B3SWFQ91.USD","SGXZ81514606.USD","IE0009G5SDU7.USD","LU2362541273.HKD","LU0708994859.HKD","TSLP","LU0072461881.USD","LU1935042488.USD","LU2404859741.USD","IE0004445015.USD","LU1803068979.SGD","TSLI","LU2237438978.USD","IE00BD6J9T35.USD","IVOO","LU2125909593.SGD","LU0949170426.SGD","QQQJ","LU0061474960.USD","LU2290526834.HKD","LU0820561818.USD","LU2506951958.HKD","SG9999014914.USD","LU1992135399.USD","LU0882574139.USD","LU0784383803.USD","LU1242518857.USD","LU2247934214.USD","LU1261432733.SGD","LU0784385170.HKD","BK4581","NVDU","LU1935042215.USD","LU1037948897.HKD","LU1868836757.USD","LU0234570918.USD","LU1670711123.USD","LU2249611893.SGD","IE00BKPKM429.USD","TSLQ","SG9999014880.SGD","LU1244550221.USD","IE00B4YYXB79.USD","LU2041044095.USD","DDM","LU0942090050.USD","NQmain","HIBL","LU1340139317.AUD","LU2237443382.USD","LU0964807845.USD","LU0265550946.USD","LU2242649171.HKD","LU2360106780.USD","NVDS","LU2272731865.HKD","LU0211328371.USD","LU0312595415.SGD","LU0994945656.USD","LU1323610961.USD","LU0894485498.HKD","NVD2.UK","TSDD","LU2023251221.USD","NVDX","MSFW","LU0553294199.USD","IE0034235303.USD","LU2362540622.SGD","LU1035773651.USD","LU1235294995.USD","LU1059921491.USD","LU1691799644.USD","IE00B3S45H60.SGD","LU0109392836.USD","LU2362541513.USD","LU2168564065.EUR","LU0095938881.EUR","LU0348723411.USD","LU0353189763.USD","LU0511384066.AUD","SG9999015978.USD","LU2322448957.HKD","LU1548497426.USD","LU2357305700.SGD","IE00BMPRXR70.SGD","LU0175139822.USD","SPYM","LU1127390331.HKD","IE00BKVL7J92.USD","LU1032955483.USD","LU2505996509.AUD","QLD","IE0009356076.USD","LU0476273544.USD","BK4099","SGXZ99366536.SGD","VTI","LU2361044865.SGD","BK4535","BK4527","LU0784384876.USD","LU1868836591.USD","LU2552382215.SGD","LU1934455194.USD","LU1633808545.USD","LU0080751232.USD","MSFX","LU0203202063.USD","LU0225283273.USD","LU0642271901.SGD","LU1914381329.SGD","BK4576","LU2065169927.USD","LU2125909247.SGD","LU2028103732.USD","LU0823417653.USD","LU2764262908.HKD","LU0256863902.USD","EHC","LU0960925559.SGD","BK4549","IE00BBT3K403.USD","LU0048584097.USD","BK4612","LU0353189680.USD","LU0057025933.USD","LU0289739343.SGD","LU2083900584.USD","IE00BKDWB100.SGD","LU2294711713.HKD","LU0211327993.USD","LU1235295455.SGD","LU2089284900.SGD","TSII","MOH","LU0354030438.USD","LU2210150020.SGD","LU2602419157.SGD","SG9999015358.SGD","TSLO","LU1935042991.SGD","TSLZ","SG9999015986.USD","IE00BN8TJ469.HKD","IE00BLSP4239.USD","BK4528","LU2148611432.USD","BK4529","LU0557290698.USD","LU0070217475.USD","TSYW.SI","LU1228905540.USD","IE0034235188.USD","LU2168564495.EUR","LU0082616367.USD","BK4554","IE00B19Z9505.USD","SDS","LU0985320562.USD","LU0081259029.USD","LU2272731600.USD","LU0011850046.USD","LU0267386448.USD","LU1720051017.SGD","IE00BK4W5M84.HKD","LU1804176565.USD","LU2417539215.USD","LU2065171311.SGD","LU2237443465.HKD","XDTE","SG9999014906.USD","IE00B7KXQ091.USD","LU1244550577.SGD","LU0965509283.SGD","LU2191332357.HKD","DJX","VOOV","LU1670628061.USD","BK4551","LU0149725797.USD","LU1697837992.HKD","LU0072462426.USD","LU0127658192.USD","LU1267930730.SGD","LU2265009873.SGD","LU2023250843.SGD","IE0004445239.USD","LU0124676726.USD","LU0757359368.USD","LU1989772840.SGD","LU1934455277.USD","LU1043141396.HKD","LU0154236417.USD","LU2592432038.USD","MSFL","BK4538","LU1989773731.SGD","LU2430703095.HKD","LU0345770993.USD","LU1642822529.SGD","LU0053666078.USD","LU0786609619.USD","LU0528227936.USD","LU1670627923.USD","LU1935043023.USD","LU1852331112.SGD","LU1236620834.HKD","IE00BFXG0V08.USD","LU1989763005.USD","LU0957808578.USD","LU1582987324.SGD","LU1244550494.USD","LU0096364046.USD","LU1861127337.USD","SG9999000418.SGD","LU0314104364.USD","IE00BJTD4V19.USD","LU1232071149.USD"],"gpt_icon":1},{"id":"2609950605","title":"BRIEF-Priovant Announces Positive Phase 2 Results For Brepocitinib In Cutaneous Sarcoidosis (Cs)","url":"https://stock-news.laohu8.com/highlight/detail?id=2609950605","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609950605?lang=en_us&edition=fundamental","pubTime":"2026-02-06 21:11","pubTimestamp":1770383476,"startTime":"0","endTime":"0","summary":"BRIEF-Priovant Announces Positive Phase 2 Results For Brepocitinib In Cutaneous Sarcoidosis (Cs)Feb 6 (Reuters) - Priovant:PRIOVANT ANNOUNCES POSITIVE PHASE 2 RESULTS FOR BREPOCITINIB IN CUTANEOUS SAR","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nTUA1GHWNM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ROIV","BK4139"],"gpt_icon":0},{"id":"2609595272","title":"Priovant's Brepocitinib Shows Skin Disease Improvement in Phase 2 Study; Pulmovant Completes Lung Disease Trial Enrollment","url":"https://stock-news.laohu8.com/highlight/detail?id=2609595272","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609595272?lang=en_us&edition=fundamental","pubTime":"2026-02-06 21:07","pubTimestamp":1770383220,"startTime":"0","endTime":"0","summary":"Roivant Sciences' (ROIV) unit Priovant Therapeutics said Friday the phase 2 study of its experimental drug, brepocitinib, showed improvement in cutaneous sarcoidosis disease activity at higher doses, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ROIV","BK4007","BK4139"],"gpt_icon":0},{"id":"2609595373","title":"Shares of Roivant up 15.8% Premarket After Experimental Drug Shows Benefit in Rare Skin Disease, Q3 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2609595373","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609595373?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:58","pubTimestamp":1770382691,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nL6N3Z20SU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4139","ROIV"],"gpt_icon":0},{"id":"2609859351","title":"Roivant Sciences posts nine-month revenue of USD 5.74 million, down 73 percent","url":"https://stock-news.laohu8.com/highlight/detail?id=2609859351","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609859351?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:32","pubTimestamp":1770381159,"startTime":"0","endTime":"0","summary":"Roivant Sciences Ltd. reported its financial results for the nine months ended December 31, 2025. Total revenue for the period was USD 5.74 million. The company recorded a net loss attributable to shareholders of USD 602.77 million for the nine-month period. Research and development expenses totaled USD 482.87 million, while cost of revenues amounted to USD 0.97 million. Income tax expense was USD 34.98 million for the same period. For the third quarter, Roivant Sciences reported revenue of USD 5.74 million and a net loss attributable to shareholders of USD 265.89 million. During the period, Roivant Sciences continued to advance its pipeline, which includes brepocitinib, a small molecule inhibitor of TYK2 and JAK1 being developed for dermatomyositis, non-infectious uveitis, and cutaneous sarcoidosis. The pipeline also features IMVT-1402 and batoclimab, fully human monoclonal antibodies targeting FcRn and being developed for several IgG-mediated autoimmune indications. The company reaff","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDL29q63X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ROIV","BK4007","BK4139"],"gpt_icon":0},{"id":"2609526593","title":"S&P 500 Futures Climb In Premarket Trading; Doximity, Stellantis Lag","url":"https://stock-news.laohu8.com/highlight/detail?id=2609526593","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609526593?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:31","pubTimestamp":1770381060,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Barrons.com using technology from Automated Insights.With U.S. stock markets set to open in two hours, Encompass Health Corp.  was up 16.6% in pre-market trading, and Bloom Energy Corp.  was up 12.4%.Roblox Corp. , Reddit Inc. , and Roivant Sciences Ltd.  were all posting gains of at least 9%. In early trading, Doximity Inc.  and Stellantis N.V.  had posted declines, falling 30.7% and 27.0%, respectively.Meanwhile S&P 500 futures were up 0.54%, with futures for the Dow Jones Industrial Average rising 0.50%. The Cboe Volatility Index futures were up 11.88%.In commodities news, Brent crude oil futures were down 0.64%, and gold futures were up 0.39%. Bitcoin climbed 4.27% to $66,312.In the previous regular trading session, the S&P 500 and the Dow were down 1.23% and 1.20%, respectively. Stocks in Asia were mixed overnight, with Japan's NIKKEI 225 Index up 0.81% and China's Shanghai Composite Index down 0.25%.In afternoon trading, stocks in Europ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0054578231.USD","STLA","LU0823414551.USD","MESmain","DOCS","BK4613","LU2357125470.USD","LU2290526834.HKD","LU2237957811.SGD","BK4007","LU1983260115.SGD","RDTL","SPLV","LU1861215975.USD","SPXS","SPXU","BK4598","LU2506951792.HKD","BK4554","UPRO","LU1642822529.SGD","BK4559","OEF","SH","ESmain","EHC","LU1861220033.SGD","BK4077","LU0823414478.USD","BK4550","ROIV","BK4539","HIBL","LU2264538146.SGD","LU1064927863.SGD","BK4541","OEX","BK4565","IVOO","BMAY","BK4099","LU1815336760.USD","BK4581","VOOV","BK4185","SGXZ23171101.USD","BK4182","BK4588","LU0476273544.USD","XDTE","BK4534","LU1861558580.USD","LU2360107168.USD","LU2237957902.USD","LU2294711713.HKD","IE0001KFT4U8.USD","LU0957808578.USD","LU0444971666.USD","LU1861559042.SGD","BK4547","LU1988902786.USD","IVW","SG9999004303.SGD","LU0444973449.USD","BK4167","BK4585","SPYM","GPIX","SPYV","BK4551","BK4085","BK4504","IVV","SSO","LU2543165471.USD","LU1064131342.USD","BK4139","BK4535","SDS","VTI","SPDN","SPXL","LU2249611893.SGD","LU0348723411.USD","LU0786609619.USD"],"gpt_icon":1},{"id":"2609598448","title":"BUZZ-Roivant shares rise as experimental drug shows benefit in rare skin disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2609598448","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609598448?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:18","pubTimestamp":1770380334,"startTime":"0","endTime":"0","summary":"BUZZ-Roivant shares rise as experimental drug shows benefit in rare skin disease** Shares of developer Roivant ROIV.O up 8.8% at $23 premarket ** Co says in a midstage trial, brepocitinib improved symptoms of cutaneous sarcoidosis — a rare skin disease caused by inflammation that forms painful lumps under the skin** Higher dose improved disease activity scores by about 22 points over 16 weeks vs about 1 point for placebo, co says** More than half of treated patients reached functional remission, per investigator Dr. Misha Rosenbach** Co to start late-stage trial in 2026 after talks with U.S. FDA** Shares up ~83% in 2025  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nL4N3Z21AA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ROIV","BK4007"],"gpt_icon":0},{"id":"2609598134","title":"Roivant swings to Q3 loss as revenue drops","url":"https://stock-news.laohu8.com/highlight/detail?id=2609598134","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609598134?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:12","pubTimestamp":1770379936,"startTime":"0","endTime":"0","summary":"Roivant swings to Q3 loss as revenue dropsOverviewBiopharmaceutical firm's Q3 revenue drops to $2 mln from $9 mln yr-agoPosts Q4 net loss vs profit in year-ago quarterRoivant reported $4.5 bln in cash","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nL1N3Z20K4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ROIV","BK4139"],"gpt_icon":0},{"id":"2609598979","title":"Earnings Flash (ROIV) Roivant Sciences Posts Fiscal Q3 Net Loss $0.38 a Share, vs. FactSet Est of $0.30 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2609598979","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609598979?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:09","pubTimestamp":1770379794,"startTime":"0","endTime":"0","summary":"Earnings Flash (ROIV) Roivant Sciences Posts Fiscal Q3 Net Loss $0.38 a Share, vs. FactSet Est of $0.30 Loss","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ROIV"],"gpt_icon":0},{"id":"1130252803","title":"Stock Track | Roivant Sciences Soars 9.93% in Pre-market on Positive Phase 2 Results for Brepocitinib","url":"https://stock-news.laohu8.com/highlight/detail?id=1130252803","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130252803?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:09","pubTimestamp":1770379741,"startTime":"0","endTime":"0","summary":"Roivant Sciences Ltd. (ROIV) experienced a significant pre-market surge of 9.93% on Friday. The sharp upward movement follows the release of encouraging clinical trial data from one of its subsidiary...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ROIV"],"gpt_icon":0},{"id":"2609598617","title":"Immunovant Q3 net loss smaller than expected","url":"https://stock-news.laohu8.com/highlight/detail?id=2609598617","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609598617?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:08","pubTimestamp":1770379698,"startTime":"0","endTime":"0","summary":"Immunovant Q3 net loss smaller than expectedOverviewClinical-stage immunology firm's Q3 net loss beat analyst expectationsCompany completed $550 mln financing, extending cash runway for IMVT-1402 laun","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nL1N3Z20K1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ROIV","BK4588","BK4585","BK4139","IMVT"],"gpt_icon":0},{"id":"2609598501","title":"Roivant Sciences Q3 Adj. EPS $(0.24) Beats $(0.32) Estimate, Sales $1.999M","url":"https://stock-news.laohu8.com/highlight/detail?id=2609598501","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609598501?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:07","pubTimestamp":1770379672,"startTime":"0","endTime":"0","summary":"Roivant Sciences (NASDAQ:ROIV) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.32) by 24.53 percent. This is a 20 percent decrease over losses of $(0.20) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/02/50441594/roivant-sciences-q3-adj-eps-0-24-beats-0-32-estimate-sales-1-999m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ROIV","BK4007","BK4139"],"gpt_icon":0},{"id":"2609704560","title":"BRIEF-Roivant Sciences Q3 Revenue USD 1.999 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2609704560","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609704560?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:00","pubTimestamp":1770379247,"startTime":"0","endTime":"0","summary":"BRIEF-Roivant Sciences Q3 Revenue USD 1.999 Million\n\n\nFeb 06 (Reuters) - Roivant Sciences Q3 operating expenses USD 341.152 million.\n\nQ3 net income USD -313.701 million\nQ3 income from operations USD -339.153 million vs. IBES estimate USD -306.4 million\nQ3 EPS USD -0.38","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nPLX483A67:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","ROIV"],"gpt_icon":0},{"id":"2609556002","title":"Priovant Therapeutics kündigt positive Phase-2-Studie mit Brepocitinib bei kutaner Sarkoidose an","url":"https://stock-news.laohu8.com/highlight/detail?id=2609556002","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609556002?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:00","pubTimestamp":1770379221,"startTime":"0","endTime":"0","summary":"Priovant Therapeutics, ein Tochterunternehmen von Roivant Sciences Ltd., hat positive Ergebnisse der Phase-2-Studie BEACON zur Wirksamkeit von Brepocitinib bei kutaner Sarkoidose bekannt gegeben. Die Daten wurden bereits vorgestellt. Brepocitinib zeigte in der Studie eine gute Vertrglichkeit, ohne schwerwiegende Nebenwirkungen, und alle beobachteten Nebenwirkungen wurden als leicht oder moderat eingestuft. Priovant plant, nach Rücksprache mit der FDA im Kalenderjahr 2026 ein Phase-3-Programm für kutane Sarkoidose zu starten.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Roivant Sciences Ltd. published the original content used to generate this news brief via GlobeNewswire  on February 06, 2026, and is solely responsible for the inform","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDLbXX4Pf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU2210150020.SGD","SG9999014021.USD","SG9999014039.USD","ROIV","BK4112","LU0314104364.USD","IE00BKPKM429.USD","IE00BGHQF748.EUR","SG9999014013.SGD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU2095319765.USD","BK4588","SG9999014005.SGD","NDAQ","BK4007","BK4585","LU2210149790.SGD"],"gpt_icon":0},{"id":"2609656008","title":"Roivant Sciences Q3 Operating Expenses USD 341.152 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2609656008","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609656008?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:00","pubTimestamp":1770379202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nPLX483A67:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4139","ROIV"],"gpt_icon":0},{"id":"2609560070","title":"Roivant Sciences Ltd - Brepocitinib 45 Mg Shows Significant Improvement in Cutaneous Sarcoidosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2609560070","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609560070?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:00","pubTimestamp":1770379202,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nPLX483A67:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ROIV","BK4139"],"gpt_icon":0},{"id":"2609159835","title":"Roivant Sciences Ltd: Jury Trial in the U.S. Moderna Case Scheduled for March 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2609159835","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609159835?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:00","pubTimestamp":1770379202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nPLX483A67:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ROIV","BK4139","BK4007"],"gpt_icon":0},{"id":"2609600595","title":"Roivant Announces Positive Phase 2 Results for Brepocitinib in Cutaneous Sarcoidosis (Cs) and Reports Financial Results for the Third Quarter Ended December 31, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2609600595","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609600595?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:00","pubTimestamp":1770379201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nTUABSJDFC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ROIV","BK4139","BK4007"],"gpt_icon":0},{"id":"2609598358","title":"Roivant Sciences Ltd - Topline Results Expected in Second Half of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2609598358","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609598358?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:00","pubTimestamp":1770379201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nTUA4PNQ9S:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ROIV","BK4007","BK4139"],"gpt_icon":0},{"id":"2609061560","title":"Pulmovant Announces Completion of Enrollment in the Phase 2 Phocus Study of Mosliciguat in Patients With Pulmonary Hypertension Associated With Interstitial Lung Disease (Ph-Ild)","url":"https://stock-news.laohu8.com/highlight/detail?id=2609061560","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609061560?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:00","pubTimestamp":1770379201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nTUA4PNQ9S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4007","ROIV"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":3,"totalSize":125,"code":"91000000","status":"200"}]}}